Anna Gardin: Incredible Initiative to Measure Clinician’s Own Lp(a) On The Spot at ESOC 2026
Anna Gardin, Neurology Resident at Stroke Unit, “G. Martino” University Hospital, shared on LinkedIn:
”At ESOC 2026, an incredible initiative gave clinicians the chance to measure their own Lp(a) on the spot.
As healthcare professionals, we talk to our patients about cardiovascular risk every day, but how often do we actually look at our own?
Fortunately, my Lp(a) are low (<15 nmol/L).
But this kind of screening is a powerful reminder: elevated Lp(a) can be the nudge we need to double down on the modifiable factors we can control.
And for those with high levels?
The good news is that the therapeutic landscape is evolving.
Novel Lp(a)-lowering agents are on the horizon, and the science is moving fast.
Lead by example. Know your risk.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?